Show Summary Details
Page of

RASA1 and Capillary Malformation–Arteriovenous Malformation 

RASA1 and Capillary Malformation–Arteriovenous Malformation
RASA1 and Capillary Malformation–Arteriovenous Malformation

Nicole Revencu

, Laurence M. Boon

, John B. Mulliken

, and Miikka Vikkula

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 25 February 2021

RASA1 encodes P120RASGTPase-activating protein (P120RASGAP), a small intracellular protein, involved in RAS regulation. Mutations in this gene result in capillary malformation–arteriovenous malformation (CM–AVM; OMIM 608354), an autosomal dominant disorder (Eerola et al., 2003) with high penetrance and variable expressivity. Small, multifocal and randomly distributed capillary malformations are the hallmark of the phenotype. In addition, about one-third of patients have a fast-flow lesion, which can involve the skin, the subcutaneous tissue, the muscles, the bones, the brain or the spine. Parkes Weber syndrome is part of the phenotype. So far, 101 distinct mutations have been identified in 133 unrelated families and most of them suggest loss-of-function (de Wijn et al., 2012; Eerola et al., 2003; Hershkovitz et al., 2008a; Hershkovitz et al., 2008b; Revencu et al., submitted; Revencu et al., 2008; Thiex et al., 2010; Wooderchak-Donahue et al., 2012).

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.